IL6 and neoplasm: Properties of quercetin, and other identified compounds, that reduce IL-6 and IL-10 show promise as a potential anti-cancer therapeutic, though reductions in TNF and IL-12 may not be favourable for anti-tumour activity as these cytokines can promote the anti-tumour response [197,198].